These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 22503000

  • 1. How can elderly apolipoprotein E ε4 carriers remain free from dementia?
    Ferrari C, Xu WL, Wang HX, Winblad B, Sorbi S, Qiu C, Fratiglioni L.
    Neurobiol Aging; 2013 Jan; 34(1):13-21. PubMed ID: 22503000
    [Abstract] [Full Text] [Related]

  • 2. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.
    Huang W, Qiu C, von Strauss E, Winblad B, Fratiglioni L.
    Arch Neurol; 2004 Dec; 61(12):1930-4. PubMed ID: 15596614
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY, Sadovnick AD, Feldman H.
    CMAJ; 2004 Oct 12; 171(8):863-7. PubMed ID: 15477624
    [Abstract] [Full Text] [Related]

  • 6. The effect of MAPT H1 and APOE ε4 on transition from mild cognitive impairment to dementia.
    Samaranch L, Cervantes S, Barabash A, Alonso A, Cabranes JA, Lamet I, Ancín I, Lorenzo E, Martínez-Lage P, Marcos A, Clarimón J, Alcolea D, Lleó A, Blesa R, Gómez-Isla T, Pastor P.
    J Alzheimers Dis; 2010 Oct 12; 22(4):1065-71. PubMed ID: 20930301
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The association between APOE ε4 and Alzheimer-type dementia among memory clinic patients is confined to those with a higher education. The DESCRIPA Study.
    Vermeiren AP, Bosma H, Visser PJ, Zeegers MP, Graff C, Ewers M, Frisoni GB, Frölich L, Hampel H, Jones RW, Kehoe PG, Lenoir H, Minthon L, Nobili FM, Olde Rikkert M, Rigaud AS, Scheltens P, Soininen H, Spiru L, Tsolaki M, Wahlund LO, Vellas B, Wilcock G, Elias-Sonnenschein LS, Verhey FR.
    J Alzheimers Dis; 2013 Oct 12; 35(2):241-6. PubMed ID: 23380990
    [Abstract] [Full Text] [Related]

  • 9. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R.
    Arch Neurol; 2005 Jun 12; 62(6):975-80. PubMed ID: 15956169
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
    Villalpando-Berumen JM, Mejia-Arango S, Aguilar-Salinas CA, Ordonez-Sanchez ML, Gutierrez-Robledo LM.
    J Am Geriatr Soc; 2008 Apr 12; 56(4):677-82. PubMed ID: 18205760
    [Abstract] [Full Text] [Related]

  • 11. Synergistic effect between apolipoprotein E ε4 and diabetes mellitus for dementia: result from a population-based study in urban China.
    Zhao Q, Xiong Y, Ding D, Guo Q, Hong Z.
    J Alzheimers Dis; 2012 Apr 12; 32(4):1019-27. PubMed ID: 22890095
    [Abstract] [Full Text] [Related]

  • 12. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B, Carson R, Barrett SL, Craig D, Passmore AP.
    Neurosci Lett; 2010 Oct 08; 483(1):62-6. PubMed ID: 20678545
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA, Charfeddine B, Lammouchi T, Harrabi I, Ben Othman L, Dridi H, Bennamou S, Limem K.
    Neurosci Lett; 2008 Aug 01; 440(2):145-9. PubMed ID: 18555606
    [Abstract] [Full Text] [Related]

  • 15. APOE-related mortality: effect of dementia, cardiovascular disease and gender.
    Rosvall L, Rizzuto D, Wang HX, Winblad B, Graff C, Fratiglioni L.
    Neurobiol Aging; 2009 Oct 01; 30(10):1545-51. PubMed ID: 18237822
    [Abstract] [Full Text] [Related]

  • 16. Low diastolic pressure and risk of dementia in very old people: a longitudinal study.
    Qiu C, Winblad B, Fratiglioni L.
    Dement Geriatr Cogn Disord; 2009 Oct 01; 28(3):213-9. PubMed ID: 19752556
    [Abstract] [Full Text] [Related]

  • 17. Work-related physical activity and the risk of dementia and Alzheimer's disease.
    Rovio S, Kåreholt I, Viitanen M, Winblad B, Tuomilehto J, Soininen H, Nissinen A, Kivipelto M.
    Int J Geriatr Psychiatry; 2007 Sep 01; 22(9):874-82. PubMed ID: 17721898
    [Abstract] [Full Text] [Related]

  • 18. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M, Figuera-Terré L, Mulet-Pérez B, Arrufat-Cardús MT, Pascual San Emeterio A, Arbeola-Rigau I, Labad-Alquézar A, Vilella-Cuadrada E.
    Rev Neurol; 2007 Sep 01; 38(9):801-7. PubMed ID: 15152345
    [Abstract] [Full Text] [Related]

  • 19. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease.
    Rovio S, Kåreholt I, Helkala EL, Viitanen M, Winblad B, Tuomilehto J, Soininen H, Nissinen A, Kivipelto M.
    Lancet Neurol; 2005 Nov 01; 4(11):705-11. PubMed ID: 16239176
    [Abstract] [Full Text] [Related]

  • 20. The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment.
    Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Berry-Kravis E, Bennett DA.
    Neurocase; 2005 Feb 01; 11(1):3-7. PubMed ID: 15804918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.